Solid Biosciences Reports First Quarter 2018 Financial Results and Provides Business Update

Author's Avatar
May 10, 2018
Article's Main Image

Company Finalizing Response to FDA Regarding Clinical Hold on SGT-001 Phase I/II Clinical Trial